While the drugmaker reaffirmed its 2025 revenue guidance of $61bn to $64bn, it raised its full-year 2025 profit outlook. Pfizer now expects to earn $2.90 to $3.10 per share, compared with its previous ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

UK Court of Appeal upholds key Moderna patent against Pfizer and BioNTech | Comirnaty vaccine ruled to infringe European mRNA technology patent. Already registered? If you don't have a login or your ...

HHS Secretary Robert F. Kennedy Jr. has upended the way Covid vaccines are approved and for whom they’re recommended, ...

As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.

In this lighthearted throwback, I imagine taking kindergarten attendance in 2025, featuring creative names inspired by the COVID era. As a teacher, I reflect with humor on how times have changed, ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million-pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals ...